These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 10197961)

  • 1. Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitis.
    Tselios T; Probert L; Daliani I; Matsoukas E; Troganis A; Gerothanassis IP; Mavromoustakos T; Moore GJ; Matsoukas JM
    J Med Chem; 1999 Apr; 42(7):1170-7. PubMed ID: 10197961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide.
    Wauben MH; Joosten I; Schlief A; van der Zee R; Boog CJ; van Eden W
    J Immunol; 1994 Apr; 152(8):4211-20. PubMed ID: 7511673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of experimental allergic encephalomyelitis (EAE) induced by guinea pig myelin basic protein epitope 72-85 with a human MBP(87-99) analogue and effects of cyclic peptides.
    Tselios T; Daliani I; Probert L; Deraos S; Matsoukas E; Roy S; Pires J; Moore G; Matsoukas J
    Bioorg Med Chem; 2000 Aug; 8(8):1903-9. PubMed ID: 11003134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental allergic encephalomyelitis (EAE): role of B cell and T cell epitopes in the development of EAE in Lewis rats.
    Hashim GA; Day ED; Carvalho E; Abdelaal A
    J Neurosci Res; 1987; 17(4):375-83. PubMed ID: 2442406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective T helper cell epitope responsible for the failure of region 69-84 of the human myelin basic protein to induce experimental allergic encephalomyelitis in the Lewis rat.
    Hashim GA; Galang AB; Srinivasan JV; Carvalho EF; Offner H; Vandenbark AA; Cleveland WL; Day ED
    J Neurosci Res; 1989 Oct; 24(2):222-30. PubMed ID: 2479765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cyclic Altered Peptide Analogue Based on Myelin Basic Protein 87-99 Provides Lasting Prophylactic and Therapeutic Protection Against Acute Experimental Autoimmune Encephalomyelitis.
    Emmanouil M; Tseveleki V; Triantafyllakou I; Nteli A; Tselios T; Probert L
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29385090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72-85.
    Tselios T; Daliani I; Deraos S; Thymianou S; Matsoukas E; Troganis A; Gerothanassis I; Mouzaki A; Mavromoustakos T; Probert L; Matsoukas J
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2713-7. PubMed ID: 11133075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes.
    Samson MF; Smilek DE
    J Immunol; 1995 Sep; 155(5):2737-46. PubMed ID: 7544383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of entire myelin basic protein-induced experimental autoimmune encephalomyelitis in Lewis rats by major histocompatibility complex class II-binding competitor peptides.
    Wauben MH; Kozhich A; Joosten I; Schlief A; Boog CJ; van Eden W
    Eur J Immunol; 1994 May; 24(5):1053-60. PubMed ID: 7514128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative bioactive conformations of amide linked cyclic myelin basic protein peptide analogues associated with experimental autoimmune encephalomyelitis.
    Spyranti Z; Dalkas GA; Spyroulias GA; Mantzourani ED; Mavromoustakos T; Friligou I; Matsoukas JM; Tselios TV
    J Med Chem; 2007 Nov; 50(24):6039-47. PubMed ID: 17979262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A putative bioactive conformation for the altered peptide ligand of myelin basic protein and inhibitor of experimental autoimmune encephalomyelitis [Arg91, Ala96] MBP87-99.
    Mantzourani ED; Tselios TV; Grdadolnik SG; Brancale A; Platts JA; Matsoukas JM; Mavromoustakos TM
    J Mol Graph Model; 2006 Sep; 25(1):17-29. PubMed ID: 16310386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity of region 65-102 of the myelin basic protein.
    Hashim GA; Day ED; Fredane L; Intintola P; Carvalho E
    J Neurosci Res; 1986; 16(3):467-78. PubMed ID: 2430104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR structural elucidation of myelin basic protein epitope 83-99 implicated in multiple sclerosis.
    Spyranti Z; Tselios T; Deraos G; Matsoukas J; Spyroulias GA
    Amino Acids; 2010 Mar; 38(3):929-36. PubMed ID: 19468823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific.
    Issazadeh S; Kjellén P; Olsson T; Mustafa M; Holmdahl R
    Eur J Immunol; 1997 Jun; 27(6):1584-7. PubMed ID: 9209515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of encephalitogenic and immunodominant epitopes of guinea pig myelin basic protein (Gp-BP) in Lewis rats tolerized neonatally with Gp-BP or Gp-BP peptides.
    Vandenbark AA; Vainiene M; Celnik B; Hashim GA; Buenafe A; Offner H
    J Immunol; 1994 Jul; 153(2):852-61. PubMed ID: 7517426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical requirement for aspartic acid at position 82 of myelin basic protein 73-86 for recruitment of V beta 8.2+ T cells and encephalitogenicity in the Lewis rat.
    Smeltz RB; Wauben MH; Wolf NA; Swanborg RH
    J Immunol; 1999 Jan; 162(2):829-36. PubMed ID: 9916705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on T-cell receptors involved in experimental autoimmune encephalomyelitis using the complementary peptide recognition approach.
    Xian CJ; Simmons RD; Willenborg DO; Vandenbark AA; Hashim GA; Carnegie PR
    J Neurosci Res; 1995 Aug; 41(5):620-7. PubMed ID: 7563242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cyclic CCK8 analogue selective for the cholecystokinin type A receptor: design, synthesis, NMR structure and binding measurements.
    De Luca S; Ragone R; Bracco C; Digilio G; Aloj L; Tesauro D; Saviano M; Pedone C; Morelli G
    Chembiochem; 2003 Nov; 4(11):1176-87. PubMed ID: 14613109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist: structural implications for the MHC II (I-Au)-peptide complex from docking calculations.
    Tzakos AG; Fuchs P; van Nuland NA; Troganis A; Tselios T; Deraos S; Matsoukas J; Gerothanassis IP; Bonvin AM
    Eur J Biochem; 2004 Aug; 271(16):3399-413. PubMed ID: 15291817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined NMR and molecular dynamics simulation study to determine the conformational properties of agonists and antagonists against experimental autoimmune encephalomyelitis.
    Mantzourani ED; Blokar K; Tselios TV; Matsoukas JM; Platts JA; Mavromoustakos TM; Grdadolnik SG
    Bioorg Med Chem; 2008 Mar; 16(5):2171-82. PubMed ID: 18207413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.